Clinical Trials
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-8902
Phase I Trial of Doxorubicin plus Carboplatin with GM-CSF in Patients with Advanced, Previously Treated Cancer
Activated
04-15-1990
Closed
05-01-1992
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9011
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Hodgkin's Disease
Research Committee(s)
Lymphoma
Activated
04-15-1990
Closed
12-01-1995
Closed
Phase
Accrual
80%
Published
SWOG Clinical Trial Number
SWOG-8932
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Activated
04-01-1990
Closed
07-15-2009
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-8916
Evaluation of Merbarone in Pancreatic Adenocarcinoma
Activated
03-15-1990
Closed
06-15-1991
Closed
Phase
Accrual
48%
Published
SWOG Clinical Trial Number
SWOG-8944
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma
Activated
03-01-1990
Closed
06-01-1991
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
SWOG-8866
Evaluation of Piroxantrone in Advanced and Metastatic (Stage IV) Non-Small Cell Lung Cancer
Activated
03-01-1990
Closed
05-01-1991
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8915
Study of 6-Thioguanine Administered as 120 Hour Continuous Infusion for Refractory or Recurrent Small Cell Lung Carcinoma
Activated
03-01-1990
Closed
12-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8940
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer
Activated
03-01-1990
Closed
11-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8942
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
03-01-1990
Closed
12-15-1994
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-8923
Neo-FAC for Poor Prognosis Stage IV Breast Cancer, A Phase II Pilot Study
Research Committee(s)
Breast Cancer
Activated
02-15-1990
Closed
06-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8921
Trials of Cyclophosphamide, IL-2, DTIC/IL-2, and DTIC/Cisplatin/Tamoxifen in Stage IV Melanoma
Research Committee(s)
Melanoma
Activated
02-15-1990
Closed
09-01-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8994 (EST-C-0690) (INT-0086)
Evaluation of Quality of Life in Patients with Stage C Adenocarcinoma of the Prostate Enrolled on SWOG-8794 (INT-0086)
Activated
02-15-1990
Closed
01-01-1997
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8906
Evaluation of Merbarone in Hepatoma, Phase II
Activated
02-01-1990
Closed
05-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8910
Evaluation of Low Dose Continuous 5-Fluorouracil (5-FU) and Weekly Cis-Platinum (CDDP) in Advanced Adenocarcinoma of the Stomach
Activated
01-15-1990
Closed
08-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8842
Dihydroxyazacytidine in Malignant Mesothelioma, Phase II
Research Committee(s)
Sarcoma
Activated
12-15-1989
Closed
11-15-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8943
Evaluation of Merbarone in Advanced Soft-Tissue Sarcomas
Activated
12-15-1989
Closed
07-01-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8894 (INT-0105) (EST-2889)
A Comparison of Bilateral Orchiectomy with or without Flutamide for the Treatment of Patients with Histologically Confirmed Stage D2 Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1989
Closed
09-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8917
5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot
Activated
12-01-1989
Closed
02-15-1992
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
SWOG-8903
Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
11-15-1989
Closed
11-01-1993
Closed
Phase
Accrual
82%
Published
SWOG Clinical Trial Number
SWOG-8828
A Phase II Trial of Carboplatin (CBDCA) in Relapsed or Refractory Acute Myeloid Leukemia
Activated
11-15-1989
Closed
10-15-1992